bpc-157 negative effects BPC-157: Tendon Repair and More BPC-157 Peptide Therapy in South
Description
However, long-term human safety trials are lacking, so usage should be approached with caution

Development of auto-antibodies Some cobalamin preparations in rare cases can stimulate an allergenic response where there is development of antibodies to the cobalmin injected

The practical difference for patients is that the two peptides are discussed through different biological frameworks

AOD-9604 2mg is offered by AMP for qualified research professionals and laboratory use

Per BNF and BSH guidance: For confirmed deficiency without neurological involvement: 1 mg IM on alternate days for two weeks, then 1 mg every two to three months for maintenance
